Correction: Risk for Valvular Heart Disease among Fenfluramine and Dexfenfluramine Users

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and …

This 100-word excerpt has been provided in the absence of an abstract.

| Table of Contents

This Article

  1. Ann Intern Med January 18, 2000 vol. 132 no. 2 167
  1. » ExcerptFREE

Comments

  1. Submit a comment
  2. No comments published

Share

Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement